News
While treatments like Ozempic, Mounjaro and Wegovy can provide a helping hand, there’s no magic bullet when it comes to ...
Researchers analyzed nearly 60,000 public Facebook posts to identify real-world adverse events linked to GLP-1 receptor ...
The National Pharmacy Association (NPA) has issued a warning that the burgeoning demand for weight loss injections may be ...
Some patients reluctantly shifted to save money while others have appealed for coverage of Zepbound after having experienced ...
Three women arrested when a woman fell seriously ill after using a weight loss jab, allegedly sourced from a North Yorkshire ...
Tack on a half-dozen zeros to your CVS receipt and you'll get a sense of the sticker shock afflicting state officials, insurers and hospitals dealing with the soaring cost of prescription drugs in ...
Scientists have revealed a potential 'neurobiotic' sixth sense derived from direct communication between microorganisms and ...
2d
The Print on MSNMounjaro, Wegovy signal ashift in obesity care model in India which sees 20k bariatric surgeries a year
India's anti-obesity drug market is valued at Rs 3,000-3,500 crore and is projected to grow nearly eightfold to Rs 25,000 ...
GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...
A spokesperson said: “Results from the STEP trials demonstrate that weight regain is likely once medication is stopped.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results